Access cutting-edge chronic kidney disease treatment through this clinical trial at a research site in Orlando. Study-provided care at no cost to qualified participants.
Access chronic kidney disease specialists in Orlando at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic kidney disease treatment provided free
We will conduct a 12-month, double-blind, randomized, placebo-controlled trial to assess the effects of therapy with ferric citrate (FC) on changes in intact FGF23 levels (iFGF23, primary endpoint) in 160 pediatric patients (80 in each of the two arms) aged 6-18 years of either sex with chronic kidney disease (CKD) stages 3-4 and age-appropriate normal serum phosphate levels. Participants will be randomized to one of the two groups: 1) FC or 2) FC placebo. Participants will be recruited from 20
Sponsor: University of California, Los Angeles
Check if you qualify for this chronic kidney disease clinical trial in Orlando, FL
If you're searching for chronic kidney disease treatment options in Orlando, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Orlando research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.